Filing Flows › Profound Medical (PROF) › Q1 2026
Profound Medical (PROF) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 7, 2026
Profound Medical (PROF) reported revenue of $5.3M for the first quarter 2026 (Q1 2026), +104% from a year earlier and -11% from the quarter before. Operating margin was -150.3%, net loss $7.1M (132.2% of revenue).
Profound Medical, Q1 2026: revenue $5.3M (+104% year over year), operating margin -150.3%, net loss $7.1M, operating cash flow −$8.6M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.3M | -11% | +104% |
| Operating profit | −$8.0M | — | — |
| Net earnings | −$7.1M | — | — |
| Operating cash flow | −$8.6M | — | — |
What changed
Revenue was $5.3M in Q1 2026, up 104% year over year and down 11% from the previous quarter. Capital equipment was the largest line at 54% of revenue. Capital equipment added $2.0M year over year (up 249%), 75% of the total change.
Gross margin was 71.8%, up 1.1 points from Q1 2025. Operating costs exceeded revenue by $8.0M, an operating margin of -150.3%. Operating expenses fell 9% while revenue rose 104%. The quarter ended with a net loss of $7.1M, narrower than the previous quarter's $8.2M loss.
Operating cash flow was −$8.6M. Non-cash charges added back $100K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items used $2.7M.
Questions
What was Profound Medical's revenue in the first quarter 2026?
Profound Medical (PROF) reported revenue of $5.3M for the first quarter 2026 (Q1 2026), +104% from a year earlier and -11% from the quarter before.
Was Profound Medical profitable in the first quarter 2026?
Operating loss was $8.0M (-150.3% of revenue) and net loss $7.1M.
Source: Profound Medical 10-Q on SEC EDGAR.